RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 3.2

Open

$ 3.28

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 3.11 - $ 3.28

52 Week Range

$ 2.67 - $ 9.25

Volume

109,318

Average Volume

Market Cap

17.6M

Beta (5Y Monthly)

$ -0.04

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-15-2024	12-31-2023	10-K
2	11-14-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	03-30-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-15-2022	06-30-2022	10-Q
8	05-16-2022	03-31-2022	10-Q
9	03-15-2022	12-31-2021	10-K
10	11-15-2021	09-30-2021	10-Q
11	08-16-2021	06-30-2021	10-Q
12	05-17-2021	03-31-2021	10-Q
13	03-22-2021	12-31-2020	10-K
14	01-14-2021	11-30-2020	10-Q
15	10-14-2020	08-31-2020	10-Q
16	07-07-2020	05-31-2020	10-Q
17	05-04-2020	02-29-2020	10-K
18	01-10-2020	11-30-2019	10-Q
19	10-08-2019	08-31-2019	10-Q
20	07-03-2019	05-31-2019	10-Q
21	05-22-2019	02-28-2019	10-K
22	01-09-2019	11-30-2018	10-Q
23	10-11-2018	08-31-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Revi...
04/22/2024 10:15:41

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains ...

Benchmark Reiterates Speculative Buy on Re...
04/16/2024 13:59:36

Benchmark analyst Bruce Jackson reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Speculative Buy and maintains $17 pri...

Reviva Pharmaceuticals Q4 EPS $(0.35) Miss...
04/15/2024 12:49:57

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate...

Reviva Announces Alignment With FDA On Bri...
04/15/2024 12:33:26

Reviva To Present RECOVER Phase 3 Clinical...
03/28/2024 12:07:47

Reviva to Present RECOVER Phase 3 Clinical...
03/26/2024 12:12:57

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical co...

HC Wainwright & Co. Reiterates Buy on Revi...
03/25/2024 10:30:09

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains ...

HC Wainwright & Co. Reiterates Buy on Revi...
02/20/2024 12:19:40

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains ...

Reviva to Host KOL Event To Discuss Toplin...
02/06/2024 13:13:26

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical co...

Reviva Provides Corporate And Program Upda...
01/04/2024 13:35:37

– Schizophrenia late-stage clinical program advances with positive topline Phase 3 data, successful ongoing enrollment in open ...

HC Wainwright & Co. Reiterates Buy on Revi...
12/26/2023 11:16:58

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains ...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
12/22/2023 13:07:08

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
12/18/2023 21:31:50

Reviva Announces $30M Registered Direct Of...
11/16/2023 13:01:53

Reviva Pharmaceuticals Q3 EPS $(0.44) Miss...
11/14/2023 21:25:36

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate...

HC Wainwright & Co. Maintains Buy on Reviv...
10/31/2023 11:33:38

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and raises the ...

analyst-assessment-on-reviva-pharmaceuticals-positive-schizophrenia-trial-data---sees-more-than-200-upside-in-stock

Analyst Assessment On Reviva Pharmaceutica...
10/30/2023 17:49:18

Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are surging after the company released topline results of its pivotal...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
10/30/2023 17:30:51

Roth MKM Reiterates Buy on Reviva Pharmace...
10/30/2023 16:29:19

Roth MKM analyst Scott Henry reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $12 price target.

Reviva Pharmaceuticals Holdings Shares Res...
10/30/2023 16:20:38